There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more research is needed.

The data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.

FTSE Russell’s decision to cut Zomato parent Eternal’s investability weighting in its indices may lead to an outflow of INR 3 ...

Eli Lilly’s Zepbound proved more effective than Novo Nordisk’s Wegovy in a new head-to-head trial, though both medications ...

And if you're currently trying to lose weight or are in a caloric deficit for a certain body or fitness goal, it can be tough ...

GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...

Bishop T.D. Jakes, 67, is looking a lot leaner these days months after experiencing a serious health incident last year. Fans took notice of the Potter's ...

Researchers are beginning to wonder whether blockbuster drugs such as Wegovy, Ozempic and Zepbound could play a role in ...

Obesity and asthma are both serious health problems that many people in the U.S. face. Unfortunately, many people have to ...

Lizzo Debuts Bold Hair Transformation After Dramatic Weight Loss first appeared on Parade on May 23, 2025 Ireland Baldwin ...

Some of the most widely used and effective weight loss medications include: Metformin: Metformin works for weight loss by ...

As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.